1971
DOI: 10.1093/bja/43.1.2-a
|View full text |Cite
|
Sign up to set email alerts
|

The Pharmacological Properties in Animals of Ct1341—a New Steroid Anaesthetic Agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
74
0
5

Year Published

1976
1976
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 230 publications
(80 citation statements)
references
References 0 publications
1
74
0
5
Order By: Relevance
“…Acute exposure to levels of NS found in pregnancy leads to sedation and anesthesia (Child et al, 1971; Carl et al, 1990; Rupprecht, 2003), hence during pregnancy the mammalian brain faces the challenge to maintain an overall functional network, despite large hormonal changes. Indeed many women experience mild to severe disturbances in their neurological performance, mostly during times of fast rise or drop in progesterone and its neuroactive metabolites (Poser et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…Acute exposure to levels of NS found in pregnancy leads to sedation and anesthesia (Child et al, 1971; Carl et al, 1990; Rupprecht, 2003), hence during pregnancy the mammalian brain faces the challenge to maintain an overall functional network, despite large hormonal changes. Indeed many women experience mild to severe disturbances in their neurological performance, mostly during times of fast rise or drop in progesterone and its neuroactive metabolites (Poser et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…Several years later, this led to the development of steroidal anesthetics (Child et al, 1971). Of particular interest are the 3α-reduced steroid compounds, such as alphaxalone, which display potent anesthetic properties.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the relatively large injection volume, no muscle damage was observed [5]. Alphaxalone-alphadolone was solubilised with Cremophor®-EL, which resulted in adverse effects in dogs, cats, and humans [11,12] and consequently it was withdrawn from the market. Recently, a new formulation of alphaxalone without alphadalone and solubilised with the aid of cyclodextrin rather than Cremophor®-EL became available (Alfaxan®).…”
Section: Introductionmentioning
confidence: 99%